Committees

20 October 2021 - Impact of the Protocol on the provision of medicines to Northern Ireland - Oral evidence

Protocol on Ireland/Northern Ireland Sub-Committee
Impact of the Protocol on the provision of medicines to Northern Ireland

Wednesday 20 October 2021

Start times: 3:30pm (private) 4:00pm (public)


Add to calendar

Meeting details

At 3:30pm: Private discussion
Work Impact of the Protocol on the provision of medicines to Northern Ireland (Non-inquiry session)
At 4:00pm: Oral evidence
Work Impact of the Protocol on the provision of medicines to Northern Ireland (Non-inquiry session)
Open PDF
219KB
Open HTML
1MB
Martin Sawer
Executive Director at Healthcare Distribution Association
Michelle Riddalls
Chief Executive at PAGB, the consumer healthcare assocaition
Paul Williams
Senior Director Corporate Affairs at Teva UK

Location

To be confirmed